Atlas Trials

Neuroendocrine Tumours

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neuroendocrine Tumours

RecordFirmDate
Open-Label Surufatinib in European Patients With NET (NCT04579679)Hutchmed2021-08-13
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers (NCT02923934)Olivia Newton-John Cancer Research Institute2017-08-22
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. (NCT02698410)Ipsen2016-07-01
A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours (NCT02788578)Ipsen2016-06-01
Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients (NCT02075606)Ipsen2014-05-01
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours (NCT01673906)Azienda USL Reggio Emilia - IRCCS2012-08-01
Somatuline Predictive Factors in Acromegaly and NET (NCT01840449)Ipsen2012-06-01
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours (NCT00323076)AHS Cancer Control Alberta2006-09-12
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours (NCT00326469)Ipsen2006-05-01

Track Neuroendocrine Tumours automatically

Every clearance here is in the API, with alerts when new ones post.